The total return over the past 12 months is +50.81% vs. +16.94% for the S&P 500. So far it's up +72.27% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +50.81% | +1.65% | (13.08%) | N/A | N/A | N/A |
| Total Return CAGR | +50.81% | +1.65% | (13.08%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | +242.71% | +31.93% | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
4D Molecular Therapeutics, Inc. (FDMT)
| Year | Start price | End price | FDMT Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $7.50 | $12.92 | +72.27% | +14.51% | +57.76% |
| 2025 | $5.57 | $7.50 | +34.65% | +17.72% | +16.93% |
| 2024 | $20.26 | $5.57 | (72.51%) | +24.89% | (97.40%) |
| 2023 | $22.21 | $20.26 | (8.78%) | +26.19% | (34.97%) |
| 2022 | $21.94 | $22.21 | +1.23% | (18.17%) | +19.40% |
| 2021 | $41.45 | $21.94 | (47.07%) | +28.74% | (75.81%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
